St. Johns Investment Management Company, LLC - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 25 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
St. Johns Investment Management Company, LLC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$020.0%0.00%
Q4 2021$020.0%0.00%
Q3 2021$020.0%0.00%
Q2 2021$020.0%0.00%
Q1 2021$020.0%0.00%
Q4 2020$020.0%0.00%
Q3 2020$020.0%0.00%
Q2 2020$020.0%0.00%
Q1 2020$020.0%0.00%
Q4 2019$020.0%0.00%
Q3 2019$020.0%0.00%
Q2 2019$020.0%0.00%
Q1 2019$020.0%0.00%
Q4 2018$020.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Yu Fan 89,848$82,0000.21%
Virtu Financial LLC 153,464$141,0000.01%
HCR Wealth Advisors 21,000$19,0000.00%
Frontier Wealth Management LLC 25,000$23,0000.00%
Renaissance Technologies 1,824,839$1,674,0000.00%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 43,868$40,0000.00%
UBS Group AG 112,927$104,0000.00%
IFP Advisors, Inc 0$00.00%
OSAIC HOLDINGS, INC. 29,502$27,0000.00%
WELLS FARGO & COMPANY/MN 7,179$7,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders